NCT05731947 2026-01-29Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid TumorsSyndax PharmaceuticalsPhase 1/2 Completed42 enrolled
NCT05406817 2025-01-10Study of Radiolabeled Revumenib in Adults With Acute LeukemiaSyndax PharmaceuticalsPhase 1 Completed9 enrolled
NCT05326516 2024-08-13A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute LeukemiaSyndax PharmaceuticalsPhase 1 Completed30 enrolled